Vision therapy for convergence insufficiency and accommodative dysfunction in children
Record ID 32014000408
Authors' recomendations: Vision dysfunction can be congenital or can result from an acquired brain injury, and is characterized by abnormalities in accommodation and vergence such as convergence insufficiency and accommodative dysfunction. Convergence insufficiency is an impairment of binocular vision, i.e., the inability for both eyes to work together when looking at something that is near. Signs include intermittent exotropia (one eye may turn outward), reduced near point of convergence (NPC), and reduced convergence amplitudes. Common symptoms include double vision (diplopia), eyestrain, intermittent blurring, motion sickness, inability to concentrate, headaches, and a generalized decrease in visual awareness or constricted fields, among others. Quality of life is impacted in children with impaired binocular vision since it affects reading, sports, and other activities. The American Academy of Optometry (AAO) estimates that the median prevalence of convergence insufficiency in the population is 7%, and that the prevalence is similar for adults and children. Standard therapy for visual dysfunction can be categorized broadly as optical correction, including added lens power and prism; pharmaceutical agents; extraocular muscle surgery; and vision therapy.
Project Status: Completed
Year Published: 2013
URL for published report: The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=16084
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
- Vision Disorders
- Ocular Motility Disorders
- Vision, Binocular
- Accommodation, Ocular
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: 2013 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.